Mr. Randy D. Stevenson
President
DeVere Manufacturing Inc.
1923 Beloit Avenue
Janesville , WI 53546
United States
rstevenson@deverechemical.comFEI 3012088459Issued Nov 12, 2025Center for Drug Evaluation and Research (CDER)
Source: FDA, published letter. FDA published this warning letter; View Letter opens FDA's copy. To check it, open FDA's record for this establishment, listed under FEI 3012088459.
Violations5
Issue DateNov 12, 2025
Product TypeDrugs
StatusOpen
Letter Details
Firm
DeVere Manufacturing Inc.
Location
Mr. Randy D. Stevenson
President
DeVere Manufacturing Inc.
1923 Beloit Avenue
Janesville , WI 53546
United States
rstevenson@deverechemical.com
FEI Number
3012088459
Country
United States
Issue Date
November 12, 2025
Issuing Office
Center for Drug Evaluation and Research (CDER)
Product Type
Drugs
Status
Open
Summary
DeVere Manufacturing Inc. received a warning letter for manufacturing over-the-counter hand sanitizer products on equipment also used for non-pharmaceutical products such as acidic toilet cleaners, creating unacceptable cross-contamination risks. The FDA inspection (June 2-4, 2025) identified failures to establish and follow adequate written procedures for equipment cleaning and maintenance in violation of Current Good Manufacturing Practice (CGMP) regulations, rendering the firm's drug products adulterated. The company's response commitment to implement cleaning records and validation procedures was deemed inadequate, as CGMP standards prohibit using shared equipment for both drug and non-pharmaceutical manufacturing due to the potential for active ingredient and product residue contamination.
DeVere Manufacturing Inc. FDA Warning Letter, November 12, 2025